Nasopharyngeal carcinoma: an evolving paradigm
The past three decades have borne witness to many advances in the understanding of the
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus …
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus …
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Cell-free DNA (cfDNA) derived from tumours is present in the plasma of cancer patients. The
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
[HTML][HTML] Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation
JE Gold, RA Okyay, WE Licht, DJ Hurley - Pathogens, 2021 - mdpi.com
Pathogens | Free Full-Text | Investigation of Long COVID Prevalence and Its Relationship to
Epstein-Barr Virus Reactivation Next Article in Journal Epidemiological Aspects of Maternal …
Epstein-Barr Virus Reactivation Next Article in Journal Epidemiological Aspects of Maternal …
[HTML][HTML] Anti–Epstein–Barr virus BNLF2b for mass screening for nasopharyngeal cancer
T Li, F Li, X Guo, C Hong, X Yu, B Wu… - … England Journal of …, 2023 - Mass Medical Soc
Background Population screening of asymptomatic persons with Epstein–Barr virus (EBV)
DNA or antibodies has improved the diagnosis of nasopharyngeal carcinoma and survival …
DNA or antibodies has improved the diagnosis of nasopharyngeal carcinoma and survival …
[HTML][HTML] Epstein-Barr virus and systemic autoimmune diseases
G Houen, NH Trier - Frontiers in immunology, 2021 - frontiersin.org
Epstein-Barr Virus (EBV) is an extremely successful human herpes virus, which infects
essentially all human beings at some time during their life span. EBV infection and the …
essentially all human beings at some time during their life span. EBV infection and the …
Circulating tumor DNA and liquid biopsy in oncology
Techniques for analyzing circulating tumor DNA (ctDNA) to detect, characterize and monitor
cancer have matured rapidly. An increasing body of clinical evidence is demonstrating the …
cancer have matured rapidly. An increasing body of clinical evidence is demonstrating the …
Toward the early detection of cancer by decoding the epigenetic and environmental fingerprints of cell-free DNA
Y Van Der Pol, F Mouliere - Cancer cell, 2019 - cell.com
Widespread adaptation of liquid biopsy for the early detection of cancer has yet to reach
clinical utility. Circulating tumor DNA is commonly detected though the presence of genetic …
clinical utility. Circulating tumor DNA is commonly detected though the presence of genetic …
Epigenetic analysis of cell-free DNA by fragmentomic profiling
Cell-free DNA (cfDNA) fragmentation patterns contain important molecular information
linked to tissues of origin. We explored the possibility of using fragmentation patterns to …
linked to tissues of origin. We explored the possibility of using fragmentation patterns to …
The role of Epstein–Barr virus in nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a metastasis-prone malignancy closely associated
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: the EP-SEASON study
J Lv, LX Xu, ZX Li, L Lin, CF Wu, TQ Quan, ZC Zhen… - Cancer cell, 2024 - cell.com
Recurrence risks of cancer patient can change during treatment as a result of treatment-
related tumor evolution. However, biomarkers that can monitor these changes are lacking …
related tumor evolution. However, biomarkers that can monitor these changes are lacking …